M Rekosz

The Maria Sklodowska-Curie National Research Institute of Oncology

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Trends

Author Order

Document Type

Co-Authors

B Litwińska

National Institute of Public Health

M Kańtoch

Wojskowy Instytut Higieny i Epidemiologii

Szkoda Mt

Wojskowy Instytut Higieny i Epidemiologii

Witold Zatoński

The Maria Sklodowska-Curie National Research Institute of Oncology

J Zieliński

West Pomeranian University of Technology

Ryszard Krynicki

The Maria Sklodowska-Curie National Research Institute of Oncology

Anna Dańska-Bidzińska

Medical University of Warsaw

Andrea Bardin

University of Padua

Joanna Jońska‐Gmyrek

Radom College

Jolanta Kupryjańczyk

The Maria Sklodowska-Curie National Research Institute of Oncology

Cooperative Institutions

The Maria Sklodowska-Curie National Research Institute of Oncology

Centrum Onkologii

Centre International de Recherche sur le Cancer

National Institute of Public Health

Vrije Universiteit Amsterdam

Medical University of Warsaw

Wojskowy Instytut Higieny i Epidemiologii

Heidelberg University

German Cancer Research Center

Cardinal Stefan Wyszyński University in Warsaw

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Field

Human papillomavirus infection in women with and without cervical cancer in Warsaw, Poland

European Journal of Cancer (2008)

Andrea Bardin Salvatore Vaccarella Gary M. Clifford Jolanta Lissowska M Rekosz

10.1016/j.ejca.2007.12.001

Cite

Citations (94)

[Papillomaviruses and herpesviruses as selected risk factors in the etiopathogenesis of cervix neck cancer. I. Use of nucleic acid hybridization for diagnosing HPV infections].

PubMed (1999)

Szkoda Mt M Rekosz B Litwińska M Kańtoch

HPV infections are regarded as the main etiological factor responsible for the presence of cytological abnormalities and the primary risk factor for cervical cancer development. Diagnostic materials were collected between 1995 and 1997 in the Gynecologic Cancer Prevention, Cancer Center Institute of Oncology, Memorial Hospital Maria Skłodowska-Curie, Warsaw. The patients were divided into three groups: group C--women suspected for viral infection during clinical or cytological examination and two comparative groups A and B--women invited for routine cytological examination. Cytological smears for nucleic acid hybridisation collected before cytological smear sampling with a dacron swab (groups A and C) or collected after cytological smear sampling with a cervical brush (group B) were used. Cytological and clinical data was also used in the investigation. In 52% of the 236 samples tested by nucleic acid hybridisation HPV DNA was found to be present. DNA from the high/intermediate HPV risk group was also present in 36% of the samples and in 11% of the samples from the low risk HPV group. In 5% of the samples we confirmed the presence of mixed infections from both HPV risk groups. The results obtained from nucleic acid hybridisation with pap smear results were compared. It was observed that HPV infections from the high risk group occurred more frequently in pap 3 and pap 4 test results; HPV infections from the low risk group occurred more frequently in pap 1 and pap 2 results, while mixed infections from both risk groups occurred particularly in pap 4 and pap 5 results. Women in the 35-45 age groups suffered more frequently from infections from the high/intermediate risk group. In the 25-35 and 55-65 age groups HPV infections from the low risk group occurred more frequently. In the comparative groups only 2.6% of the women were infected with HPV.

Etiology

Papanicolaou Test

Source

Cite

Citations (0)

Interlaboratory agreement in assessment of gynaecological cytology in Cervical Cancer Screening Programme in Poland – a pilot evaluation

Polish Journal of Pathology (2021)

Kinga Zalewska-Otwinowska Anna Macios Katarzyna Komerska M Rekosz Andrzej Nowakowski

ENWEndNote BIBJabRef, Mendeley RISPapers, Reference Manager, RefWorks, Zotero AMA Zalewska-Otwinowska K, Macios A, Komerska K, Rekosz M, Nowakowski A. Interlaboratory agreement in assessment of gynaecological cytology in Cervical Cancer Screening Programme in Poland – a pilot evaluation. Polish Journal of Pathology. 2021;72(1):75-83. doi:10.5114/pjp.2021.106445. APA Zalewska-Otwinowska, K., Macios, A., Komerska, K., Rekosz, M., & Nowakowski, A. (2021). Interlaboratory agreement in assessment of gynaecological cytology in Cervical Cancer Screening Programme in Poland – a pilot evaluation. Polish Journal of Pathology, 72(1), 75-83. https://doi.org/10.5114/pjp.2021.106445 Chicago Zalewska-Otwinowska, Kinga, Anna Macios, Katarzyna Komerska, Małgorzata Rekosz, and Andrzej Nowakowski. 2021. "Interlaboratory agreement in assessment of gynaecological cytology in Cervical Cancer Screening Programme in Poland – a pilot evaluation". Polish Journal of Pathology 72 (1): 75-83. doi:10.5114/pjp.2021.106445. Harvard Zalewska-Otwinowska, K., Macios, A., Komerska, K., Rekosz, M., and Nowakowski, A. (2021). Interlaboratory agreement in assessment of gynaecological cytology in Cervical Cancer Screening Programme in Poland – a pilot evaluation. Polish Journal of Pathology, 72(1), pp.75-83. https://doi.org/10.5114/pjp.2021.106445 MLA Zalewska-Otwinowska, Kinga et al. "Interlaboratory agreement in assessment of gynaecological cytology in Cervical Cancer Screening Programme in Poland – a pilot evaluation." Polish Journal of Pathology, vol. 72, no. 1, 2021, pp. 75-83. doi:10.5114/pjp.2021.106445. Vancouver Zalewska-Otwinowska K, Macios A, Komerska K, Rekosz M, Nowakowski A. Interlaboratory agreement in assessment of gynaecological cytology in Cervical Cancer Screening Programme in Poland – a pilot evaluation. Polish Journal of Pathology. 2021;72(1):75-83. doi:10.5114/pjp.2021.106445.

Concordance

Bethesda system

Telepathology

10.5114/pjp.2021.106445

Cite

Citations (1)

Screening for cervical cancer in Poland.

PubMed (1993)

Z Wronkowski J Zieliński M Rekosz

Despite the growing number of PAP tests performed in Poland every year, (approximately 3 million per year in 1992) the mortality rates of cervical cancer are stable or increasing. With the intention of changing this unfavourable situation, a team of specialists in 1988 has developed a model for cervical cancer screening in Poland. Six experimental centres were chosen for the implementation of this model. The principles of the screening system were as follows: 1) population-based; 2) individual invitations; 3) computer assisted; 4) reproducible; 5) cytotechnicians' participation; 6) target population 30-60 years; 7) frequency of PAP tests: every 3 years. Preliminary data from the population of 25,841 which was covered by the screening campaign in Warsaw showed a 70.1% attendance rate and detectability of 3 cases per 1,000 screened women.

Attendance

Cancer screening

Source

Cite

Citations (1)

Uterine cervix cancer – can its mortality be reduced in Poland?

Contemporary Oncology/Współczesna Onkologia (2003)

Janusz J. Zielinski M Rekosz

Source

Cite

Citations (0)

Wirusy papilloma i herpes oraz wybrane czynniki ryzyka w etiopatogenezie raka szyjki macicy. I. Zastosowanie hybrydyzacji kwasow nukleinowych do wykrywania zakazen HPV

Medycyna Doświadczalna i Mikrobiologia (1999)

Marek Tomasz Szkoda M Rekosz B Litwińska M Kańtoch

Source

Cite

Citations (0)

[Papillomaviruses and herpesviruses as selected risk factors in the etiopathogenesis of cervix neck cancer. II. Use of PCR for isolating DNA of human papillomavirus and Herpes simplex].

PubMed (1999)

Szkoda Mt M Rekosz B Litwińska M Kańtoch

The aims of the study were to compare polymerase chain reaction PCR with nucleic acid hybridisation HC in the routine diagnosis of HPV infections. Smears collected for PCR were digested for 24 hours using proteinase K. After DNA extraction 174 samples were tested by PCR with human bglobin primers PG04-GH20. The PCR products were separated in 2% agarose gel electrophoresis stained with ethidium bromide. In 80.6% of the samples 256 base pair DNA fragments were observed in the gel in UV light. These samples were tested by PCR with HPV primers MY09-MY11. In 40% of the samples the presence of HPV DNA was confirmed. Next we carried out PCR using a mixture of two pairs of primers bglobin PG04-GH20 and HPV MY09-MY11. DNA for this study was extracted from 24 samples in which the presence of human DNA was not confirmed in the first PCR test and from 7 untested samples. In 21 cases HPV DNA was found to be present in gel electrophoresis. The presence of HPV DNA was confirmed in 44.75% of the samples.

Ethidium bromide

Agarose gel electrophoresis

Agarose

Source

Cite

Citations (0)